田晓寅;左亚刚;刘跃华;孙秋宁;

• 1:中国医学科学院 北京协和医学院 北京协和医院皮肤科

摘要(Abstract)：

<正>药物不良反应以皮肤受累最为常见。随着新药的不断上市和临床工作的不断深入开展,几乎所有种类的药物都被发现可以诱发皮肤不良反应。除皮肤外,药物也会同时影响其他器官,形成特定的自身免疫性疾病。此外,药物也可以成为诱发皮肤恶性肿瘤的危险因素。本文针对药物诱发的自身免疫性疾病和肿瘤性皮肤病,试就诱发疾病的药物种类、疾病的临床特点和可能的机制进行综述。药物性狼疮

关键词(KeyWords)： 皮肤不良反应;药物诱发;自身免疫性疾病;皮肤癌

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 田晓寅;左亚刚;刘跃华;孙秋宁;

Email:

DOI:

参考文献(References)：

• [1]Hoffman BJ.Sensitivity of sulfadiazine resembling acute dis-seminated lupus erythematosus[J].Arch Dermatol Syph,1945,51:190-192.
• [2]Marzano AV,Vezzoli P,Crosti C.Drug-induced lupus:an update on its dermatologic aspects[J].Lupus,2009,18:935-940.
• [3]Marzano AV,Lazzari R,Polloni I,et al.Drug-induced sub-acute cutaneous lupus erythematosus:evidence for differ-ences from its idiopathic counterpart[J].Br J Dermatol,2011,165:335-341.
• [4]Peroni A,Zini A,Braga V,et al.Drug-induced morphea:report of a case induced by balicatib and review of the litera-ture[J].J Am Acad Dermatol,2008,59:125-129.
• [5]Haustein UF,Haupt B.Drug-induced scleroderma and scle-rodermiform conditions[J].Clin Dermatol,1998,16:353-366.
• [6]Rünger TM,Adami S,Benhamou CL,et al.Morphea-like skin reactions in patients treated with the cathepsin K inhibi-tor balicatib[J].J Am Acad Dermatol,2012,66:89-96.
• [7]Maehana T,Mizuno T,Muto M,et al.Scleroderma-like skin sclerosis induced by docetaxel chemotherapy for hor-mone refractory prostate cancer:a case report[J].Nihon Hinyokika Gakkai Zasshi,2010,101:726-729.
• [8]Itoh M,Yanaba K,Kobayashi T,et al.Taxane-induced scleroderma[J].Br J Dermatol,2007,156:363-367.
• [9]Bonaci-Nikolic B,Nikolic MM,Andrejevic S,et al.Anti-neutrophil cytoplasmic antibody(ANCA)-associated autoim-mune diseases induced by antithyroid drugs:comparison with idiopathic ANCA vasculitides[J].Arthritis Res Ther,2005,7:1072-1081.
• [10]Dolman KM,Gans ROB,Vervatt TJ,et al.Vasculitis and antineutrophil cytoplasmic autoantibodies associated with pro-pylthiouracil therapy[J].Lancet,1993,342:651-652.
• [11]Calaas-Continente A,Espinosa M,Manzano-García G,et al.Necrotizing glomerulonephritis and pulmonary hemor-rhage associated with carbimazole therapy[J].Thyroid,2005,15:286-288.
• [12]Batchelor N,Holley A.A fatal case of propylthiouracil-in-duced ANCA-positive vasculitis[J].MedGenMed,2006,8:10.
• [13]Kimura S,Ikeda-Saito M.Human myeloperoxidase and thy-roid peroxidase,two enzymes with separate and distinct physi-ological functions,are evolutionarily related members of the same gene family[J].Proteins,1988,3:113-120.
• [14]Jiang X,Khursigara G,Rubin RL.Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils[J].Science,1994,266:810-813.
• [15]Radic'M,Martinovic'Kaliterna D,Radic'J.Drug-induced vasculitis:a clinical and pathological review[J].Neth J Med,2012,70:12-17.
• [16]Nozato K,Morishima Y,Furuta J,et al.A case of Henoch-Schnlein purpura which was difficult to distinguish from a skin rash associated with gefitinib[J].Nihon Kokyuki Gak-kai Zasshi,2010,48:529-534.
• [17]Yuba T,Nagata K,Shiotsu S,et al.Henoch-schnlein pur-pura induced by erlotinib(Tarceva):a case report[J].Nihon Kokyuki Gakkai Zasshi,2010,48:81-85.
• [18]Aktas B,Topcuoglu P,Kurt OK,et al.Severe Henoch-Schnlein purpura induced by cytarabine[J].Ann Pharma-cother,2009,43:792-793.
• [19]Park SJ,Kim JH,Shin JI.Is there a link between the use of etanercept and Henoch-Schnlein purpura Comment on:Henoch-Schonlein purpura in a patient with the rheumatoid arthritis receiving etanercept[J].Eur J Dermatol,2011,21:147.
• [20]Pellegrini F,Rossi V,Fassone F,et al.Henoch-Schnlein purpura and aromatase inhibitors[J].Eur J Dermatol,2009,19:519-520.
• [21]Borrás-Blasco J,Enriquez R,Amoros F,et al.Henoch-Schnlein purpura associated with clarithromycin.Case re-port and review of literature[J].Int J Clin Pharmacol Ther,2003,41:213-216.
• [22]Brenner S,Bialy-Golan A,Ruocco V.Drug-induced pem-phigus[J].Clin Dermatol,1998,16:393-397.
• [23]Goldberg I,Shirazi I,Brenner S.In vitro interferon-gamma release test in patients with drug-induced pemphigus[J].Isr Med Assoc J,2008,10:424-427.
• [24]冯素英,周武庆,靳培英.药物诱发天疱疮6例分析[J].临床皮肤科杂志,2011,40:396-399.
• [25]Tang X,Zhang X.Drug-induced pemphigus after six years of treatment with phenytoin and carbamazepine[J].Int J Dermatol,2012,51:485-486.
• [26]刘冰,左亚刚.药物诱发大疱性类天疱疮[J].国际皮肤性病学杂志,2012,38:235-238.
• [27]Berg D,Otley C.Skin cancer in organ transplant recipients:epidemiology,pathogenesis and management[J].J Am Acad Dermatol,2002,47:1-17.
• [28]Tessari G,Naldi L,Boschiero L,et al.Incidence and clini-cal predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer:a multicenter cohort study[J].Arch Derma-tol,2010,146:294-299.
• [29]Subramaniam K,Pavli P.Risk of non-melanoma skin cancer with thiopurine use in inflammatory bowel disease[J].J Gastroenterol Hepatol,2012,27:193-194.
• [30]O'Donovan P,Perrett CM,Zhang X,et al.Azathioprine and UVA light generate mutagenic oxidative DNA damage[J].Science,2005,309:1871-1874.
• [31]Epaulard O,Leccia MT,Blanche S,et al.Phototoxicity and photocarcinogenesis associated with voriconazole[J].Med Mal Infect,2011,41:639-645.
• [32]McCarthy KL,Playford EG,Looke DF,et al.Severe photo-sensitivity causing multifocal squamous cell carcinomas sec-ondary to prolonged voriconazole therapy[J].Clin InfectDis,2007,44:55-56.
• [33]Brunel AS,Fraisse T,Lechiche C,et al.Multifocal squa-mous cell carcinomas in an HIV-infected patient with a long-term voriconazole therapy[J].AIDS,2008,22:905-906.
• [34]Miller DD,Cowen EW,Nguyen JC,et al.Melanoma asso-ciated with long-term voriconazole therapy:a new manifesta-tion of chronic photosensitivity[J].Arch Dermatol,2010,146:300-304.
• [35]Arnault JP,Mateus C,Escudier B,et al.Skin tumors in-duced by sorafenib;paradoxic RAS-RAF pathway activation and oncogenic mutations of HRAS,TP53,and TGFBR1[J].Clin Cancer Res,2012,18:263-272.
• [36]Sanli H,Ataman S,Akay BN,et al.Mycosis fungoides in a patient with ankylosing spondylitis during infliximab therapy[J].J Drugs Dermatol,2007,6:834-836.
• [37]Dommasch E,Gelfand JM.Is there truly a risk of lymphoma from biologic therapies[J].Dermatol Ther,2009,22:418-430.